Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1854, Issue 9, 2015, Pages 1138-1149

  Ruggieri, Silverio ^a   Orsomando, Giuseppe ^a   Sorci, Leonardo ^a   Raffaelli, Nadia ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Enzyme regulation; NAD biosynthesis; Nicotinamide phosphoribosyltransferase; Nicotinamide riboside kinase; Nicotinic acid phosphoribosyltransferase; Quinolinate phosphoribosyltransferase

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE RIBOSIDE; NICOTINATE PHOSPHORIBOSYLTRANSFERASE; PHOSPHORIBOSYLTRANSFERASE; QUINOLINATE PHOSPHORIBOSYLTRANSFERASE; SIRTUIN; UNCLASSIFIED DRUG; GLYCOSYLTRANSFERASE; NICOTINATE-NUCLEOTIDE DIPHOSPHORYLASE (CARBOXYLATING);

ARTICLE; BIOAVAILABILITY; CATALYSIS; CELL AGING; CELL FUNCTION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; HOMEOSTASIS; HUMAN; MAMMAL CELL; METABOLISM; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; ASSOCIATION; BIOSYNTHESIS; PHYSIOLOGY;

MAMMALIA;

ANIMALS; CUES; HUMANS; NAD; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PENTOSYLTRANSFERASES; SIRTUINS;

EID: 84937524287     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2015.02.021     Document Type: Review

References (174)

1. S. Oka, C.P. Hsu, and J. Sadoshima Regulation of cell survival and death by pyridine nucleotides Circ. Res. 111 2012 611 627
2. A. Burkle, and L. Virag Poly(ADP-ribose): PARadigms and PARadoxes Mol. Aspects Med. 34 2013 1046 1065
3. K.L. Feijs, P. Verheugd, and B. Luscher Expanding functions of intracellular resident mono-ADP-ribosylation in cell physiology FEBS J. 280 2013 3519 3529
4. W. Wei, R. Graeff, and J. Yue Roles and mechanisms of the CD38/cyclic adenosine diphosphate ribose/Ca(2 +) signaling pathway World J. Biol. Chem. 5 2014 58 67
5. A.H. Guse, I.M. Ernst, and R. Fliegert NAADP signaling revisited Curr. Top. Med. Chem. 13 2013 2978 2990
6. H.C. Chang, and L. Guarente SIRT1 and other sirtuins in metabolism Trends Endocrinol. Metab. 25 2014 138 145
7. R.H. Houtkooper, E. Pirinen, and J. Auwerx Sirtuins as regulators of metabolism and healthspan Nat. Rev. Mol. Cell Biol. 13 2012 225 238
8. M.O. Hottiger, P.O. Hassa, B. Luscher, H. Schuler, and F. Koch-Nolte Toward a unified nomenclature for mammalian ADP-ribosyltransferases Trends Biochem. Sci. 35 2010 208 219
9. M. Pittelli, L. Formentini, G. Faraco, A. Lapucci, E. Rapizzi, F. Cialdai, G. Romano, G. Moneti, F. Moroni, and A. Chiarugi Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool J. Biol. Chem. 285 2010 34106 34114
10. N.A. Berger, J.L. Sims, D.M. Catino, and S.J. Berger Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage: studies in normal and DNA-repair defective cells Princess Takamatsu Symp. 13 1983 219 226
11. P. Aksoy, T.A. White, M. Thompson, and E.N. Chini Regulation of intracellular levels of NAD: a novel role for CD38 Biochem. Biophys. Res. Commun. 345 2006 1386 1392
12. C. Canto, and J. Auwerx Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol. Rev. 64 2012 166 187
13. + and sirtuins in aging and disease Trends Cell Biol. 24 2014 464 471
14. L. Mouchiroud, R.H. Houtkooper, and J. Auwerx NAD(+) metabolism: a therapeutic target for age-related metabolic disease Crit. Rev. Biochem. Mol. Biol. 48 2014 397 408
15. S. Wang, X. Yang, Y. Lin, X. Qiu, H. Li, X. Zhao, L. Cao, X. Liu, Y. Pang, X. Wang, and Z. Chi Cellular NAD depletion and decline of SIRT1 activity play critical roles in PARP-1-mediated acute epileptic neuronal death in vitro Brain Res. 1535 2013 14 23
16. H. Krenzlin, I. Demuth, B. Salewsky, P. Wessendorf, K. Weidele, A. Burkle, and M. Digweed DNA damage in Nijmegen Breakage Syndrome cells leads to PARP hyperactivation and increased oxidative stress PLoS Genet. 8 2012 e1002557
17. + depletion or PAR polymer formation: which plays the role of executioner in ischaemic cell death? Acta Physiol. (Oxf) 203 2011 225 234
18. + depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death J. Neurosci. 30 2010 2967 2978
19. K. Weidele, A. Kunzmann, M. Schmitz, S. Beneke, and A. Burkle Ex vivo supplementation with nicotinic acid enhances cellular poly(ADP-ribosyl)ation and improves cell viability in human peripheral blood mononuclear cells Biochem. Pharmacol. 80 2010 1103 1112
20. S.J. Won, B.Y. Choi, B.H. Yoo, M. Sohn, W. Ying, R.A. Swanson, and S.W. Suh Prevention of traumatic brain injury-induced neuron death by intranasal delivery of nicotinamide adenine dinucleotide J. Neurotrauma 29 2012 1401 1409
21. C. Sheng, H. Chen, B. Wang, T. Liu, Y. Hong, J. Shao, X. He, Y. Ma, H. Nie, N. Liu, W. Xia, and W. Ying NAD(+) administration significantly attenuates synchrotron radiation X-ray-induced DNA damage and structural alterations of rodent testes Int. J. Physiol. Pathophysiol. Pharmacol. 4 2012 1 9
22. + depletion and reduced Sir2alpha deacetylase activity J. Biol. Chem. 280 2005 43121 43130
23. A.A. Sauve, C. Munshi, H.C. Lee, and V.L. Schramm The reaction mechanism for CD38. A single intermediate is responsible for cyclization, hydrolysis, and base-exchange chemistries Biochemistry 37 1998 13239 13249
24. Y.J. Zhao, C.M. Lam, and H.C. Lee The membrane-bound enzyme CD38 exists in two opposing orientations Sci. Signal. 5 2012 ra67
25. + glycohydrolase by site directed mutagenesis of key active site residues Biochim. Biophys. Acta 1844 2014 1317 1331
26. J.H. Shrimp, J. Hu, M. Dong, B.S. Wang, R. MacDonald, H. Jiang, Q. Hao, A. Yen, and H. Lin Revealing CD38 cellular localization using a cell permeable, mechanism-based fluorescent small-molecule probe J. Am. Chem. Soc. 136 2014 5656 5663
27. -/- mouse Biochem. Biophys. Res. Commun. 346 2006 188 192
28. P. Aksoy, C. Escande, T.A. White, M. Thompson, S. Soares, J.C. Benech, and E.N. Chini Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38 Biochem. Biophys. Res. Commun. 349 2006 353 359
29. M.T. Barbosa, S.M. Soares, C.M. Novak, D. Sinclair, J.A. Levine, P. Aksoy, and E.N. Chini The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity FASEB J. 21 2007 3629 3639
30. Y. Hu, H. Wang, Q. Wang, and H. Deng Overexpression of CD38 decreases cellular NAD levels and alters the expression of proteins involved in energy metabolism and antioxidant defense J. Proteome Res. 13 2014 786 795
31. T. Musso, S. Deaglio, L. Franco, L. Calosso, R. Badolato, G. Garbarino, U. Dianzani, and F. Malavasi CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines J. Leukoc. Biol. 69 2001 605 612
32. J.A. Jude, J. Solway, R.A. Panettieri Jr., T.F. Walseth, and M.S. Kannan Differential induction of CD38 expression by TNF-{alpha} in asthmatic airway smooth muscle cells Am. J. Physiol. Lung Cell. Mol. Physiol. 299 2010 L879 890
33. Y. Gao, L.H. Camacho, and K. Mehta Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-gamma/interleukin-1beta-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndrome Leuk. Res. 31 2007 455 463
34. + release in rat pulmonary arterial smooth muscle cells Am. J. Respir. Cell Mol. Biol. 52 2015 322 341
35. R. Gul, S.Y. Kim, K.H. Park, B.J. Kim, S.J. Kim, M.J. Im, and U.H. Kim A novel signaling pathway of ADP-ribosyl cyclase activation by angiotensin II in adult rat cardiomyocytes Am. J. Physiol. Heart Circ. Physiol. 295 2008 H77 88
36. F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A.L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology Physiol. Rev. 88 2008 841 886
37. M. Dileepan, J.A. Jude, S.P. Rao, T.F. Walseth, R.A. Panettieri, S. Subramanian, and M.S. Kannan MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN/AKT in human airway smooth muscle cells Respir. Res. 15 2014 107
38. L. Franco, N. Bodrato, I. Moreschi, C. Usai, S. Bruzzone, S. Scarf i, E. Zocchi, and A. De Flora Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated activation of murine N9 microglial cell line J. Neurochem. 99 2006 165 176
39. Z.N. Al-Abady, B. Durante, A.J. Moody, and R.A. Billington Large changes in NAD levels associated with CD38 expression during HL-60 cell differentiation Biochem. Biophys. Res. Commun. 442 2013 51 55
40. M. Boutant, and C. Canto SIRT1 metabolic actions: integrating recent advances from mouse models Mol. Metab. 3 2014 5 18
41. A. Satoh, C.S. Brace, N. Rensing, P. Cliften, D.F. Wozniak, E.D. Herzog, K.A. Yamada, and S. Imai Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH Cell Metab. 18 2013 416 430
42. C.A. Blum, J.L. Ellis, C. Loh, P.Y. Ng, R.B. Perni, and R.L. Stein SIRT1 modulation as a novel approach to the treatment of diseases of aging J. Med. Chem. 54 2011 417 432
43. K.G. Tanner, J. Landry, R. Sternglanz, and J.M. Denu Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose Proc. Natl. Acad. Sci. U. S. A. 97 2000 14178 14182
44. K.J. Bitterman, R.M. Anderson, H.Y. Cohen, M. Latorre-Esteves, and D.A. Sinclair Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1 J. Biol. Chem. 277 2002 45099 45107
45. + biosynthesis Science 324 2009 651 654
46. + salvage pathway by CLOCK-SIRT1 Science 324 2009 654 657
47. + metabolism and SIRT1 activity Nature 458 2009 1056 1060
48. C. Canto, L.Q. Jiang, A.S. Deshmukh, C. Mataki, A. Coste, M. Lagouge, J.R. Zierath, and J. Auwerx Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle Cell Metab. 11 2010 213 219
49. M. Fulco, Y. Cen, P. Zhao, E.P. Hoffman, M.W. McBurney, A.A. Sauve, and V. Sartorelli Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt Dev. Cell 14 2008 661 673
50. J.T. Rodgers, C. Lerin, W. Haas, S.P. Gygi, B.M. Spiegelman, and P. Puigserver Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 2005 113 118
51. H.J. Kim, J.H. Kim, S. Noh, H.J. Hur, M.J. Sung, J.T. Hwang, J.H. Park, H.J. Yang, M.S. Kim, D.Y. Kwon, and S.H. Yoon Metabolomic analysis of livers and serum from high-fat diet induced obese mice J. Proteome Res. 10 2011 722 731
52. J. Yoshino, K.F. Mills, M.J. Yoon, and S. Imai Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice Cell Metab. 14 2011 528 536
53. + metabolism oxidative stress and Sirt1 activity in Wistar rats PLoS One 6 2011 e19194
54. R.H. Skoge, C. Dolle, and M. Ziegler Regulation of SIRT2-dependent alpha-tubulin deacetylation by cellular NAD levels DNA Repair (Amst) 2014
55. A.P. Gomes, N.L. Price, A.J. Ling, J.J. Moslehi, M.K. Montgomery, L. Rajman, J.P. White, J.S. Teodoro, C.D. Wrann, B.P. Hubbard, E.M. Mercken, C.M. Palmeira, R. de Cabo, A.P. Rolo, N. Turner, E.L. Bell, and D.A. Sinclair Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging Cell 155 2013 1624 1638
56. +-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation Circ. Res. 97 2005 25 34
57. P. Bai, C. Canto, H. Oudart, A. Brunyanszki, Y. Cen, C. Thomas, H. Yamamoto, A. Huber, B. Kiss, R.H. Houtkooper, K. Schoonjans, V. Schreiber, A.A. Sauve, J. Menissier-de Murcia, and J. Auwerx PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation Cell Metab. 13 2011 461 468
58. + metabolism, protein acetylation, and treatment of metabolic syndrome Diabetes 62 2013 1084 1093
59. K.M. Ramsey, K.F. Mills, A. Satoh, and S. Imai Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice Aging Cell 7 2008 78 88
60. P.W. Caton, J. Kieswich, M.M. Yaqoob, M.J. Holness, and M.C. Sugden Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function Diabetologia 54 2011 3083 3092
61. P.W. Caton, S.J. Richardson, J. Kieswich, M. Bugliani, M.L. Holland, P. Marchetti, N.G. Morgan, M.M. Yaqoob, M.J. Holness, and M.C. Sugden Sirtuin 3 regulates mouse pancreatic beta cell function and is suppressed in pancreatic islets isolated from human type 2 diabetic patients Diabetologia 56 2013 1068 1077
62. C. Canto, R.H. Houtkooper, E. Pirinen, D.Y. Youn, M.H. Oosterveer, Y. Cen, P.J. Fernandez-Marcos, H. Yamamoto, P.A. Andreux, P. Cettour-Rose, K. Gademann, C. Rinsch, K. Schoonjans, A.A. Sauve, and J. Auwerx The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity Cell Metab. 15 2012 838 847
63. N.A. Khan, M. Auranen, I. Paetau, E. Pirinen, L. Euro, S. Forsstrom, L. Pasila, V. Velagapudi, C.J. Carroll, J. Auwerx, and A. Suomalainen Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3 EMBO Mol. Med. 6 2014 721 731
64. B. Gong, Y. Pan, P. Vempati, W. Zhao, L. Knable, L. Ho, J. Wang, M. Sastre, K. Ono, A.A. Sauve, and G.M. Pasinetti Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-gamma coactivator 1alpha regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models Neurobiol. Aging 34 2013 1581 1588
65. K.D. Brown, S. Maqsood, J.Y. Huang, Y. Pan, W. Harkcom, W. Li, A. Sauve, E. Verdin, and S.R. Jaffrey Activation of SIRT3 by the NAD(+) precursor nicotinamide riboside protects from noise-induced hearing loss Cell Metab. 20 2014 1059 1068
66. V.B. Pillai, N.R. Sundaresan, G. Kim, M. Gupta, S.B. Rajamohan, J.B. Pillai, S. Samant, P.V. Ravindra, A. Isbatan, and M.P. Gupta Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway J. Biol. Chem. 285 2010 3133 3144
67. M. Di Stefano, and L. Conforti Diversification of NAD biological role: the importance of location FEBS J. 280 2013 4711 4728
68. R.A. Billington, S. Bruzzone, A. De Flora, A.A. Genazzani, F. Koch-Nolte, M. Ziegler, and E. Zocchi Emerging functions of extracellular pyridine nucleotides Mol. Med. 12 2006 324 327
69. J.R. Revollo, A. Korner, K.F. Mills, A. Satoh, T. Wang, A. Garten, B. Dasgupta, Y. Sasaki, C. Wolberger, R.R. Townsend, J. Milbrandt, W. Kiess, and S. Imai Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme Cell Metab. 6 2007 363 375
70. N. Hara, K. Yamada, T. Shibata, H. Osago, and M. Tsuchiya Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma PLoS One 6 2011 e22781
71. + in fungi and humans Cell 117 2004 495 502
72. + metabolism J. Biol. Chem. 284 2009 158 164
73. + PLoS Biol. 5 2007 e263
74. K.L. Bogan, C. Evans, P. Belenky, P. Song, C.F. Burant, R. Kennedy, and C. Brenner Identification of Isn1 and Sdt1 as glucose- and vitamin-regulated nicotinamide mononucleotide and nicotinic acid mononucleotide [corrected] 5′-nucleotidases responsible for production of nicotinamide riboside and nicotinic acid riboside J. Biol. Chem. 284 2009 34861 34869
75. S.A. Trammell, and C. Brenner Targeted, LCMS-based metabolomics for quantitative measurement of NAD(+) metabolites Comput. Struct. Biotechnol. J. 4 2013 e201301012
76. + precursor vitamins in human nutrition Annu. Rev. Nutr. 28 2008 115 130
77. S. Garavaglia, S. Bruzzone, C. Cassani, L. Canella, G. Allegrone, L. Sturla, E. Mannino, E. Millo, A. De Flora, and M. Rizzi The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism Biochem. J. 441 2012 131 141
78. + biosynthesis in FK866-treated tumor cells J. Biol. Chem. 288 2013 25938 25949
79. + homeostasis in man Cell. Mol. Life Sci. 61 2004 19 34
80. C. Dolle, R.H. Skoge, M.R. Vanlinden, and M. Ziegler NAD biosynthesis in humans - enzymes, metabolites and therapeutic aspects Curr. Top. Med. Chem. 13 2013 2907 2917
81. J.R. Revollo, A.A. Grimm, and S. Imai The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells J. Biol. Chem. 279 2004 50754 50763
82. + levels dictate cell survival Cell 130 2007 1095 1107
83. E. Koltai, Z. Szabo, M. Atalay, I. Boldogh, H. Naito, S. Goto, C. Nyakas, and Z. Radak Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats Mech. Ageing Dev. 131 2010 21 28
84. S.R. Costford, S. Bajpeyi, M. Pasarica, D.C. Albarado, S.C. Thomas, H. Xie, T.S. Church, S.A. Jubrias, K.E. Conley, and S.R. Smith Skeletal muscle NAMPT is induced by exercise in humans Am. J. Physiol. Endocrinol. Metab. 298 2010 E117 126
85. J. Brandauer, S.G. Vienberg, M.A. Andersen, S. Ringholm, S. Risis, P.S. Larsen, J.M. Kristensen, C. Frosig, L. Leick, J. Fentz, S. Jorgensen, B. Kiens, J.F. Wojtaszewski, E.A. Richter, J.R. Zierath, L.J. Goodyear, H. Pilegaard, and J.T. Treebak AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle J. Physiol. 591 2013 5207 5220
86. P. Wang, T.Y. Xu, Y.F. Guan, W.W. Tian, B. Viollet, Y.C. Rui, Q.W. Zhai, D.F. Su, and C.Y. Miao Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway Ann. Neurol. 69 2011 360 374
87. W. Zhang, Y. Xie, T. Wang, J. Bi, H. Li, L.Q. Zhang, S.Q. Ye, and S. Ding Neuronal protective role of PBEF in a mouse model of cerebral ischemia J. Cereb. Blood Flow Metab. 30 2010 1962 1971
88. J. Bi, H. Li, S.Q. Ye, and S. Ding Pre-B-cell colony-enhancing factor exerts a neuronal protection through its enzymatic activity and the reduction of mitochondrial dysfunction in in vitro ischemic models J. Neurochem. 120 2012 334 346
89. G. Wang, T. Han, D. Nijhawan, P. Theodoropoulos, J. Naidoo, S. Yadavalli, H. Mirzaei, A.A. Pieper, J.M. Ready, and S.L. McKnight P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage Cell 158 2014 1324 1334
90. T.C. Yin, J.K. Britt, H. De Jesus-Cortes, Y. Lu, R.M. Genova, M.Z. Khan, J.R. Voorhees, J. Shao, A.C. Katzman, P.J. Huntington, C. Wassink, L. McDaniel, E.A. Newell, L.M. Dutca, J. Naidoo, H. Cui, A.G. Bassuk, M.M. Harper, S.L. McKnight, J.M. Ready, and A.A. Pieper P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury Cell Rep. 8 2014 1731 1740
91. Y. Sasaki, T. Araki, and J. Milbrandt Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy J. Neurosci. 26 2006 8484 8491
92. M. Di Stefano, I. Nascimento-Ferreira, G. Orsomando, V. Mori, J. Gilley, R. Brown, L. Janeckova, M.E. Vargas, L.A. Worrell, A. Loreto, J. Tickle, J. Patrick, J.R. Webster, M. Marangoni, F.M. Carpi, S. Pucciarelli, F. Rossi, W. Meng, A. Sagasti, R.R. Ribchester, G. Magni, M.P. Coleman, and L. Conforti A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration Cell Death Differ. 2014 10.1038/cdd.2014.164
93. L.Y. Liu, F. Wang, X.Y. Zhang, P. Huang, Y.B. Lu, E.Q. Wei, and W.P. Zhang Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases PLoS One 7 2012 e44933
94. E. van der Veer, C. Ho, C. O'Neil, N. Barbosa, R. Scott, S.P. Cregan, and J.G. Pickering Extension of human cell lifespan by nicotinamide phosphoribosyltransferase J. Biol. Chem. 282 2007 10841 10845
95. N.M. Borradaile, and J.G. Pickering Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment Aging Cell 8 2009 100 112
96. R.E. Shackelford, K. Mayhall, N.M. Maxwell, E. Kandil, and D. Coppola Nicotinamide phosphoribosyltransferase in malignancy: a review Genes Cancer 4 2013 447 456
97. M. Hasmann, and I. Schemainda FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis Cancer Res. 63 2003 7436 7442
98. U. Galli, C. Travelli, A. Massarotti, G. Fakhfouri, R. Rahimian, G.C. Tron, and A.A. Genazzani Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors J. Med. Chem. 56 2013 6279 6296
99. + biosynthesis, in human cancer cells: metabolic basis and potential clinical implications J. Biol. Chem. 288 2013 3500 3511
100. C.C. Chini, A.M. Guerrico, V. Nin, J. Camacho-Pereira, C. Escande, M.T. Barbosa, and E.N. Chini Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors Clin. Cancer Res. 20 2013 120 130
101. B. Wang, M.K. Hasan, E. Alvarado, H. Yuan, H. Wu, and W.Y. Chen NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response Oncogene 30 2011 907 921
102. S.C. Bowlby, M.J. Thomas, R.B. D'Agostino Jr., and S.J. Kridel Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells PLoS One 7 2012 e40195
103. A. Rongvaux, M. Galli, S. Denanglaire, F. Van Gool, P.L. Dreze, C. Szpirer, F. Bureau, F. Andris, and O. Leo Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress J. Immunol. 181 2008 4685 4695
104. M. Galli, F. Van Gool, A. Rongvaux, F. Andris, and O. Leo The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer Cancer Res. 70 2010 8 11
105. N. Busso, M. Karababa, M. Nobile, A. Rolaz, F. Van Gool, M. Galli, O. Leo, A. So, and T. De Smedt Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD PLoS One 3 2008 e2267
106. F. Montecucco, M. Cea, A. Cagnetta, P. Damonte, A. Nahimana, A. Ballestrero, A. Del Rio, S. Bruzzone, and A. Nencioni Nicotinamide phosphoribosyltransferase as a target in inflammation-related disorders Curr. Top. Med. Chem. 13 2013 2930 2938
107. T. Luk, Z. Malam, and J.C. Marshall Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity J. Leukoc. Biol. 83 2008 804 816
108. Z. Sun, H. Lei, and Z. Zhang Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions Cytokine Growth Factor Rev. 24 2013 433 442
109. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor Mol. Cell. Biol. 14 1994 1431 1437
110. A. Rongvaux, R.J. Shea, M.H. Mulks, D. Gigot, J. Urbain, O. Leo, and F. Andris Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis Eur. J. Immunol. 32 2002 3225 3234
111. A. Garten, S. Petzold, A. Korner, S. Imai, and W. Kiess Nampt: linking NAD biology, metabolism and cancer Trends Endocrinol. Metab. 20 2009 130 138
112. L.Q. Zhang, D.P. Heruth, and S.Q. Ye Nicotinamide phosphoribosyltransferase in human diseases J. Bioanal. Biomed. 3 2011 13 25
113. T.B. Dahl, S. Holm, P. Aukrust, and B. Halvorsen Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology Annu. Rev. Nutr. 32 2012 229 243
114. V. Audrito, S. Serra, D. Brusa, F. Mazzola, F. Arruga, T. Vaisitti, M. Coscia, R. Maffei, D. Rossi, T. Wang, G. Inghirami, M. Rizzi, G. Gaidano, J.G. Garcia, C. Wolberger, N. Raffaelli, and S. Deaglio Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia Blood 125 2015 111 123
115. E. Adeghate Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions Curr. Med. Chem. 15 2008 1851 1862
116. S. Ognjanovic, S. Bao, S.Y. Yamamoto, J. Garibay-Tupas, B. Samal, and G.D. Bryant-Greenwood Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes J. Mol. Endocrinol. 26 2001 107 117
117. M.A. Nowell, P.J. Richards, C.A. Fielding, S. Ognjanovic, N. Topley, A.S. Williams, G. Bryant-Greenwood, and S.A. Jones Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis Arthritis Rheum. 54 2006 2084 2095
118. E. Nemeth, L.S. Tashima, Z. Yu, and G.D. Bryant-Greenwood Fetal membrane distention: I. Differentially expressed genes regulated by acute distention in amniotic epithelial (WISH) cells Am. J. Obstet. Gynecol. 182 2000 50 59
119. J.G. Garcia, and L. Moreno Vinasco Genomic insights into acute inflammatory lung injury Am. J. Physiol. Lung Cell. Mol. Physiol. 291 2006 L1113 1117
120. S. Kralisch, J. Klein, U. Lossner, M. Bluher, R. Paschke, M. Stumvoll, and M. Fasshauer Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes J. Endocrinol. 185 2005 R1 8
121. R. MacLaren, W. Cui, and K. Cianflone Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes Diabetes Obes. Metab. 9 2007 490 497
122. S.K. Bae, S.R. Kim, J.G. Kim, J.Y. Kim, T.H. Koo, H.O. Jang, I. Yun, M.A. Yoo, and M.K. Bae Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1 FEBS Lett. 580 2006 4105 4113
123. H.J. Park, S.R. Kim, S.S. Kim, H.J. Wee, M.K. Bae, M.H. Ryu, and S.K. Bae Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer Oncotarget 5 2014 5087 5099
124. R. Tao, D. Wei, H. Gao, Y. Liu, R.A. DePinho, and X.C. Dong Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene J. Biol. Chem. 286 2011 14681 14690
125. + cycle drives mitochondrial oxidative metabolism in mice Science 342 2013 1243417
126. + levels and SIRT1 activity by directly targeting NAMPT Aging Cell 12 2013 1062 1072
127. D.G. Hardie Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism Proc. Nutr. Soc. 70 2007 92 99
128. P.W. Caton, J. Kieswich, M.M. Yaqoob, M.J. Holness, and M.C. Sugden Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice Diabetes Obes. Metab. 13 2011 1097 1104
129. E. Vieira, L. Marroqui, A.L. Figueroa, B. Merino, R. Fernandez-Ruiz, A. Nadal, T.P. Burris, R. Gomis, and I. Quesada Involvement of the clock gene Rev-erb alpha in the regulation of glucagon secretion in pancreatic alpha-cells PLoS One 8 2013 e69939
130. D. Friebe, M. Neef, J. Kratzsch, S. Erbs, K. Dittrich, A. Garten, S. Petzold-Quinque, S. Bluher, T. Reinehr, M. Stumvoll, M. Bluher, W. Kiess, and A. Korner Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans Diabetologia 54 2011 1200 1211
131. M. Pittelli, L. Cavone, A. Lapucci, C. Oteri, R. Felici, E. Niccolai, A. Amedei, and A. Chiarugi Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes Immunol. Cell Biol. 92 2013 191 199
132. K. Kover, P.Y. Tong, D. Watkins, M. Clements, L. Stehno-Bittel, L. Novikova, D. Bittel, N. Kibiryeva, J. Stuhlsatz, Y. Yan, S.Q. Ye, and W.V. Moore Expression and regulation of nampt in human islets PLoS One 8 2013 e58767
133. V. Audrito, S. Serra, D. Brusa, F. Mazzola, F. Arruga, T. Vaisitti, M. Coscia, R. Maffei, D. Rossi, T. Wang, G. Inghirami, M. Rizzi, G. Gaidano, J.G. Garcia, C. Wolberger, N. Raffaelli, and S. Deaglio Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia Blood 125 2015 111 123
134. M. Tanaka, M. Nozaki, A. Fukuhara, K. Segawa, N. Aoki, M. Matsuda, R. Komuro, and I. Shimomura Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway Biochem. Biophys. Res. Commun. 359 2007 194 201
135. A. Garten, S. Petzold, A. Barnikol-Oettler, A. Korner, W.E. Thasler, J. Kratzsch, W. Kiess, and R. Gebhardt Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes Biochem. Biophys. Res. Commun. 391 2010 376 381
136. T. Nakagawa, D.J. Lomb, M.C. Haigis, and L. Guarente SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle Cell 137 2009 560 570
137. A. Nikiforov, C. Dolle, M. Niere, and M. Ziegler Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation J. Biol. Chem. 286 2011 21767 21778
138. E.S. Burgos, M.C. Ho, S.C. Almo, and V.L. Schramm A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT Proc. Natl. Acad. Sci. U. S. A. 106 2009 13748 13753
139. E.S. Burgos, and V.L. Schramm Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase Biochemistry 47 2008 11086 11096
140. J.A. Khan, S. Xiang, and L. Tong Crystal structure of human nicotinamide riboside kinase Structure 15 2007 1005 1013
141. J. Li, R. Mayne, and C. Wu A novel muscle-specific beta 1 integrin binding protein (MIBP) that modulates myogenic differentiation J. Cell Biol. 147 1999 1391 1398
142. J. Li, H. Rao, D. Burkin, S.J. Kaufman, and C. Wu The muscle integrin binding protein (MIBP) interacts with alpha7beta1 integrin and regulates cell adhesion and laminin matrix deposition Dev. Biol. 261 2003 209 219
143. + in muscle morphogenesis Dev. Biol. 344 2010 809 826
144. L. Pucci, S. Perozzi, F. Cimadamore, G. Orsomando, and N. Raffaelli Tissue expression and biochemical characterization of human 2-amino 3-carboxymuconate 6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism FEBS J. 274 2007 827 840
145. M. Ikeda, H. Tsuji, S. Nakamura, A. Ichiyama, Y. Nishizuka, and O. Hayaishi Studies on the biosynthesis of nicotinamide adenine dinucleotide. II. A role of picolinic carboxylase in the biosynthesis of nicotinamide adenine dinucleotide from tryptophan in mammals J. Biol. Chem. 240 1965 1395 1401
146. + pathway Toxicol. Appl. Pharmacol. 158 1999 71 80
147. N. Kimura, T. Fukuwatari, R. Sasaki, and K. Shibata The necessity of niacin in rats fed on a high protein diet Biosci. Biotechnol. Biochem. 69 2005 273 279
148. R. Grant, and V. Kapoor Inhibition of indoleamine 2,3-dioxygenase activity in IFN-gamma stimulated astroglioma cells decreases intracellular NAD levels Biochem. Pharmacol. 66 2003 1033 1036
149. R.S. Grant, H. Naif, M. Espinosa, and V. Kapoor IDO induction in IFN-gamma activated astroglia: a role in improving cell viability during oxidative stress Redox Rep. 5 2000 101 104
150. R.S. Grant, R. Passey, G. Matanovic, G. Smythe, and V. Kapoor Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: a self-protective mechanism? Arch. Biochem. Biophys. 372 1999 1 7
151. N. Braidy, G.J. Guillemin, and R. Grant Effects of kynurenine pathway inhibition on NAD metabolism and cell viability in human primary astrocytes and neurons Int. J. Tryptophan Res. 4 2011 29 37
152. + pathway leads to energy failure and exacerbates apoptosis in pneumococcal meningitis J. Neuropathol. Exp. Neurol. 69 2010 1096 1104
153. F. Zamporlini, S. Ruggieri, F. Mazzola, A. Amici, G. Orsomando, and N. Raffaelli Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells FEBS J. 281 2014 5104 5119
154. D. Pawlak, A. Tankiewicz, T. Matys, and W. Buczko Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure J. Physiol. Pharmacol. 54 2003 175 189
155. N. Hinsch, M. Frank, C. Doring, C. Vorlander, and M.L. Hansmann QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study BMC Cancer 9 2009 93
156. + precursor quinolinic acid confers resistance of gliomas to oxidative stress Cancer Res. 73 2013 3225 3234
157. K.H. Metzeler, M. Hummel, C.D. Bloomfield, K. Spiekermann, J. Braess, M.C. Sauerland, A. Heinecke, M. Radmacher, G. Marcucci, S.P. Whitman, K. Maharry, P. Paschka, R.A. Larson, W.E. Berdel, T. Buchner, B. Wormann, U. Mansmann, W. Hiddemann, S.K. Bohlander, and C. Buske An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia Blood 112 2008 4193 4201
158. A.C. Foster, W.O. Whetsell Jr., E.D. Bird, and R. Schwarcz Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum Brain Res. 336 1985 207 214
159. S.J. Kish, F. Du, D.A. Parks, Y. Robitaille, M.J. Ball, L. Schut, O. Hornykiewicz, and R. Schwarcz Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy Ann. Neurol. 29 1991 100 104
160. F. Du, J. Williamson, E. Bertram, E. Lothman, E. Okuno, and R. Schwarcz Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells Neuroscience 55 1993 975 989
161. W. Wu, J.A. Nicolazzo, L. Wen, R. Chung, R. Stankovic, S.S. Bao, C.K. Lim, B.J. Brew, K.M. Cullen, and G.J. Guillemin Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain PLoS One 8 2013 e59749
162. S. Feldblum, A. Rougier, H. Loiseau, P. Loiseau, F. Cohadon, P.L. Morselli, and K.G. Lloyd Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue Epilepsia 29 1988 523 529
163. M. Terakata, T. Fukuwatari, M. Sano, N. Nakao, R. Sasaki, S. Fukuoka, and K. Shibata Establishment of true niacin deficiency in quinolinic acid phosphoribosyltransferase knockout mice J. Nutr. 142 2012 2148 2153
164. H. Liu, K. Woznica, G. Catton, A. Crawford, N. Botting, and J.H. Naismith Structural and kinetic characterization of quinolinate phosphoribosyltransferase (hQPRTase) from Homo sapiens J. Mol. Biol. 373 2007 755 763
165. R.K. Gholson, I. Ueda, N. Ogasawara, and L.M. Henderson The enzymatic conversion of quinolinate to nicotinic acid mononucleotide in mammalian liver J. Biol. Chem. 239 1964 1208 1214
166. H. Taguchi, and K. Iwai Inhibition of hog liver crystalline quinolinate phosphoribosyltransferase by nucleotides, quinolinate analogues and sulfhydryl reagents Agric. Biol. Chem. 40 1976 385 389
167. P.B. Collins, and S. Chaykin The management of nicotinamide and nicotinic acid in the mouse J. Biol. Chem. 247 1972 778 783
168. + and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats J. Nutr. 125 1995 1455 1461
169. N. Hara, K. Yamada, T. Shibata, H. Osago, T. Hashimoto, and M. Tsuchiya Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells J. Biol. Chem. 282 2007 24574 24582
170. L. Galassi, M. Di Stefano, L. Brunetti, G. Orsomando, A. Amici, S. Ruggieri, and G. Magni Characterization of human nicotinate phosphoribosyltransferase: kinetic studies, structure prediction and functional analysis by site-directed mutagenesis Biochimie 94 2012 300 309
171. J. Niedel, and L.S. Dietrich Nicotinate phosphoribosyltransferase of human erythrocytes. Purification and properties J. Biol. Chem. 248 1973 3500 3505
172. L.D. Smith, and R.K. Gholson Allosteric properties of bovine liver nicotinate phosphoribosyltransferase J. Biol. Chem. 244 1969 68 71
173. C.T. Grubmeyer, J.W. Gross, and M. Rajavel Energy coupling through molecular discrimination: nicotinate phosphoribosyltransferase Methods Enzymol. 308 1999 28 48
174. Z.N. Gaut, and H.M. Solomon Inhibition of nicotinate phosphoribosyltransferase in human platelet lysate by nicotinic acid analogs Biochem. Pharmacol. 20 1971 2903 2906